Selection and Characterization of a Novel DNA Aptamer, Apt-07S Specific to Hepatocellular Carcinoma Cells
Open Access
- 1 April 2020
- journal article
- research article
- Published by Taylor & Francis Ltd in Drug Design, Development and Therapy
- Vol. ume 14, 1535-1545
- https://doi.org/10.2147/DDDT.S244149
Abstract
Background: The efficacy of traditional therapeutic methods for liver cancer is unsatisfying because of the poor targeting, and inefficient drug delivery system. A recent study has proven that aptamers, developed through cell-SELEX, could specifically recognize cancer cells and show great potential in the development of a delivery system for anticancer drugs. Purpose: To develop a hepatocellular carcinoma specific aptamer using two kinds of hepatocellular carcinoma cell lines, HepG2 and SMMC-7721, as double targets and a normal hepatocyte, L02, as a negative control cell. Methods: Hepatocellular carcinoma specific aptamer was developed via cell-SELEX. The enrichment of the library was monitored by flow cytometric analysis. The specificity, affinity, and distribution of the candidate aptamer were explored. Further study was carried to assess its potential in drug delivery. Results: The library was enriched after 14 rounds of screening. Candidate aptamer Apt-07S can recognize four kinds of hepatocellular carcinoma cells and show little cell-binding ability to normal cells and four cell lines of different cancer types, revealing a high specificity of Apt-07S. Confocal imaging showed that Apt-07S distributed both on the surface and in the cytoplasm of the two target cells. Moreover, an anti-sense nucleotide to gene Plk1 (ASO-Plk1) was connected at the 3ʹ end of Apt-07S to form an integrated molecule (Apt-07S-ASO-Plk1); the functional analysis indicated that the structure of Apt-07S may help ASO-Plk1 enter the cancer cells. Conclusion: The study indicates that Apt-07S can specifically target HCC and may have potential in the delivery of anticancer drugs.Keywords
This publication has 43 references indexed in Scilit:
- Investigating the Antiproliferative Activity of High Affinity DNA Aptamer on Cancer CellsPLOS ONE, 2013
- Using Aptamers for Cancer Biomarker DiscoveryJournal of Nucleic Acids, 2013
- Targeted Delivery of Chemotherapy Agents Using a Liver Cancer-Specific AptamerPLOS ONE, 2012
- Combining use of a panel of ssDNA aptamers in the detection of Staphylococcus aureusNucleic Acids Research, 2009
- Sorafenib in Advanced Hepatocellular CarcinomaThe New England Journal of Medicine, 2008
- Cell-Specific Aptamer Probes for Membrane Protein Elucidation in Cancer CellsJournal of Proteome Research, 2008
- CD133 positive hepatocellular carcinoma cells possess high capacity for tumorigenicityInternational Journal of Cancer, 2007
- Updated treatment approach to hepatocellular carcinomaThe Esophagus, 2005
- Antisense Tcf inhibits the neoplastic growth of liver cancer cellsZeitschrift für Krebsforschung und Klinische Onkologie, 2004
- Systematic Evolution of Ligands by Exponential Enrichment: RNA Ligands to Bacteriophage T4 DNA PolymeraseScience, 1990